right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
recent
event
highlight
emerg
reemerg
pathogen
actual
becom
global
challeng
public
health
coronavirus
envelop
rna
virus
broadli
distribut
either
human
vast
major
mammal
bird
virus
possibl
caus
respiratori
enter
hepat
neurolog
diseas
coronavirus
highli
preval
mani
speci
larg
genet
divers
given
rna
suscept
frequent
recombin
mutat
genom
context
increas
humananim
interact
novel
coronavirus
like
emerg
period
newli
creat
crossspeci
pathogen
acquir
abil
infect
human
transmit
human
human
lead
occasion
spillov
event
epidem
past
year
two
strain
coronaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
potenti
public
health
worldwid
threat
sarscov
causal
agent
sever
acut
respiratori
syndrom
outbreak
guangdong
provinc
china
merscov
pathogen
respons
sever
respiratori
diseas
outbreak
middl
east
decemb
world
health
organ
china
countri
offic
inform
case
pneumonia
unknown
etiolog
detect
wuhan
citi
locat
hubei
provinc
china
associ
exposur
seafood
wet
wholesal
market
citi
new
type
coronaviru
isol
januari
januari
declar
outbreak
public
health
emerg
intern
concern
pheic
novel
coronaviru
suddenli
turn
global
health
concern
diseas
call
coronaviru
diseas
character
pandem
march
start
secondhalf
januari
scientif
literatur
particularli
focus
descript
new
viral
outbreak
main
topic
address
epidemiolog
clinic
virolog
aspect
well
possibl
public
health
choic
necessari
contain
spread
diseas
nevertheless
sever
aspect
still
unclear
thoroughli
explor
leav
grey
area
knowledg
diseas
outbreak
aim
paper
perform
bibliometr
analysi
first
paper
publish
earli
stage
outbreak
order
give
glimps
research
publish
begin
public
health
emerg
intern
concern
search
medlin
pubm
electron
databas
order
find
relev
studi
preliminari
search
start
decemb
found
first
articl
meet
inclus
criteria
publish
januari
supplementari
materi
tabl
id
subsequ
extend
research
first
day
mileston
articl
januari
decid
scan
refer
list
review
retriev
order
find
potenti
addit
pertin
articl
test
string
sensit
search
string
use
coronaviru
pneumonia
unknown
etiolog
ncov
viru
name
updat
intern
committe
taxonomi
virus
februari
yet
perform
search
use
term
ncov
sinc
presum
paper
publish
februari
februari
would
use
term
achiev
highest
sensit
decid
use
combin
keyword
avoid
mesh
term
asterisk
use
truncat
word
everi
end
asterisk
search
place
languag
restrict
english
without
limit
search
paper
classifi
basi
standard
list
key
inform
includ
digit
object
identifi
number
doi
titl
journal
name
day
first
public
onlin
paper
form
countri
first
author
affili
articl
type
sourc
data
topic
address
topic
address
identifi
accord
categori
gener
discuss
epidemiolog
virolog
patholog
clinic
present
diagnosi
therapi
transmiss
prepared
articl
address
topic
extens
way
account
one
topic
categori
paper
could
classifi
chosen
topic
categori
classifi
topic
categori
eight
us
fs
ea
eb
eb
fe
fm
fs
ss
independ
screen
identifi
articl
procedur
carri
titl
abstract
scan
order
verifi
inclus
criteria
disagr
resolv
discuss
consensu
review
disagr
persist
anoth
review
dg
call
tiebreak
number
need
read
nnr
defin
ratio
number
retriev
abstract
number
one
pertin
research
purpos
calcul
nnr
identifi
proport
paper
editori
commentari
well
proport
paper
directli
collect
data
test
use
order
test
signific
differ
comparison
percentag
use
statist
softwar
stata
statacorp
stata
statist
softwar
releas
colleg
station
tx
statacorp
llc
total
paper
retriev
articl
found
pertin
see
figur
read
extenso
order
defin
main
characterist
affili
first
author
distribut
among
countri
paper
first
author
chines
affili
first
author
affili
uk
usa
respect
first
author
affili
canada
account
total
itali
australia
korea
account
countri
account
less
first
author
affili
less
paper
editori
commentari
letter
mainli
report
data
paper
secondari
paper
mainli
narr
review
collect
knowledg
avail
point
specif
topic
ie
genom
viru
transmiss
etc
remain
origin
primari
studi
among
case
report
account
total
vitro
vivo
studi
genom
studi
account
total
remain
primari
studi
cohort
studi
case
control
studi
survey
chines
first
author
publish
origin
data
primari
studi
author
uk
usa
vs
uk
usa
p
publish
mostli
editori
commentari
note
analys
paper
use
reportednon
origin
data
use
offici
data
convers
paper
use
data
directli
collect
field
paper
sourc
data
clearli
specifi
supplementari
materi
tabl
avail
onlin
report
find
review
refer
descript
paper
select
bibliometr
analysi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
topic
content
paper
publish
gener
discuss
paper
frequent
one
total
consist
mostli
editori
commentari
origin
data
second
frequent
topic
prepared
paper
consist
commentari
paper
primari
studi
epidemiolog
topic
address
paper
primari
studi
lack
primari
studi
could
observ
also
virolog
topic
transmiss
topic
paper
report
origin
data
respect
hand
patholog
clinic
characterist
topic
consist
mostli
primari
studi
therapi
topic
address
paper
paper
primari
studi
least
address
topic
diagnosi
paper
report
origin
data
final
paper
classifi
topic
categori
tabl
id
assess
requir
expertis
capac
molecular
detect
specialis
laboratori
european
unioneuropean
econom
area
countri
paper
emphas
need
countri
put
place
strong
measur
order
detect
laboratoryconfirm
case
earli
also
highlight
need
perform
molecular
test
rtpcr
also
indic
differ
specimen
includ
nasopharyng
swab
bronchoalveolar
lavag
oropharyng
swab
nasopharyng
aspir
sputum
endo
tracheal
aspir
nasal
wash
commun
report
also
underlin
need
clinic
valid
test
specif
sensit
nasopharyng
oropharyng
swab
recommend
type
specimen
diagnost
test
interest
brief
report
publish
chines
author
supplementari
materi
publish
second
half
time
frame
select
mostli
author
chines
affili
paper
address
sever
aspect
treatment
interferon
inhal
use
efficaci
antivir
drug
potenti
repurpos
treatment
angiotensin
receptor
blocker
use
antibiot
bacteri
coinfect
respiratori
support
therapi
eg
oxygen
satur
cpap
invas
mechan
ventil
interestingli
one
paper
publish
februari
supplementari
materi
tabl
id
investig
possibl
receptor
use
infect
lung
cell
might
cellsurfac
protein
lung
alveolar
epitheli
cell
one
known
regul
endocytosi
cell
protein
kinas
author
suggest
possibl
use
highaffin
drug
inhibit
endocytosi
cell
baricitinib
oral
target
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
synthet
diseasemodifi
antirheumat
drug
use
treatment
rheumatoid
arthriti
order
reduc
viral
entri
inflamm
patient
second
half
januari
first
half
februari
proport
editori
commentari
chang
nnr
mean
pass
mean
paper
read
order
find
noneditorialcommentari
paper
mean
chanc
read
paper
directli
collect
data
increas
nnr
pass
januari
februari
novel
coronaviru
infect
emerg
two
month
ago
alreadi
discuss
new
coronaviru
isol
januari
place
emphasi
import
ensur
health
profession
research
public
best
possibl
scientif
inform
bibliometr
scientif
method
wide
use
mani
field
quantifi
analys
publish
inform
kind
literatur
analysi
first
month
first
public
pubm
show
great
number
paper
publish
expect
mainli
author
chines
affili
follow
author
uk
usa
affili
reason
distribut
ascrib
fact
china
countri
viru
origin
isol
first
one
outbreak
moreov
point
shown
commentari
publish
natur
recent
year
china
produc
scienc
phd
countri
world
chines
govern
assum
lead
role
support
scientif
research
therefor
research
public
respons
outbreak
prompt
live
give
scientif
commun
mani
element
understand
new
infect
second
countri
highest
number
public
uk
follow
usa
probabl
due
fact
prolif
countri
scientif
research
author
uk
usa
wrote
mostli
editori
commentari
public
polici
mani
import
scientif
journal
adapt
quickli
review
publish
scientif
paper
strategi
facilit
spread
new
knowledg
new
infect
outbreak
henc
import
scientif
share
paper
order
reduc
misinform
public
health
threat
earli
scientif
literatur
analys
lack
primari
studi
origin
data
expect
given
short
period
time
consid
first
pertin
public
new
infect
nevertheless
editori
news
commentari
import
share
opinion
viewpoint
expert
panel
expert
rather
produc
new
scientif
evid
varieti
sever
present
public
review
topic
need
summar
knowledg
aris
case
report
diagnost
tool
except
ct
scan
poorli
repres
discuss
especi
term
molecular
diagnosi
standard
techniqu
therapi
topic
also
poorli
repres
sinc
time
need
clinic
intervent
studi
analyz
select
time
frame
percentag
editori
news
commentari
decreas
highlight
particularli
analysi
show
second
half
januari
first
half
februari
proport
editori
commentari
lower
nnr
thu
indic
increas
level
evid
produc
well
increas
primari
data
avail
sever
limit
studi
first
base
research
pubm
index
scientif
impact
journal
strongli
recommend
consult
one
relev
databas
perform
systemat
review
literatur
even
though
report
highqual
articl
like
includ
cochran
review
index
pubm
addit
exclud
public
english
acknowledg
given
outbreak
start
china
may
led
partial
select
bia
nevertheless
paper
exclud
written
chines
english
abstract
greatest
part
report
chines
govern
data
shown
consid
articl
publish
februari
take
account
literatur
chang
daybyday
topic
extend
bibliometr
research
next
month
would
paramount
import
conclus
far
know
earli
review
first
bibliometr
studi
analyz
earli
scientif
research
output
quantit
descript
standpoint
due
huge
amount
interest
concern
relat
outbreak
analysi
show
scientif
public
reactiv
still
preliminar
expect
deficit
origin
data
excess
editori
commentari
research
need
review
synthes
grow
knowledg
special
aim
import
knowledg
gap
term
diagnosi
effect
prevent
therapeut
measur
author
declar
support
organis
submit
work
financi
relationship
organis
might
interest
submit
work
previou
three
year
relationship
activ
could
appear
influenc
submit
work
author
receiv
financi
support
research
authorship
andor
public
articl
author
declar
data
relev
studi
includ
articl
upload
supplementari
inform
supplementari
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
r
e
g
r
n
g
j
u
r
n
l
p
u
b
l
c
n
e
e
e
b
e
c
n
e
c
u
v
e
f
e
b
r
u
r
h
u
e
h
e
f
c
h
e
p
p
e
r
w
e
r
e
l
r
e
n
e
x
e
n
e
l
n
e
b
e
p
u
b
e
h
e
e
n
w
e
p
e
r
f
r
e
u
r
e
r
c
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
